Atomoxetine

Common brands: Strattera, Atoncy, Lamictal Xr, Lamictal Odt, Lamictal

Top reporter: Eli Lilly And Company

Nonsteroidal Anti-inflammatory Drug [EPC]Anti-epileptic Agent [EPC]Atypical Antipsychotic [EPC]Mood Stabilizer [EPC]Corticosteroid [EPC]
23,432
Total Reports
3,284
Serious Reports
1,367
Death Reports
30
Reported Reactions
Death Report Ratio: High (5.83%)

Patient Demographics

Male
12,774
Female
9,181

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Atomoxetine.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 2,358
7.2%
2 NAUSEA 1,837
5.6%
3 FATIGUE 1,827
5.6%
4 VOMITING 1,462
4.5%
5 HEADACHE 1,432
4.4%
6 DIZZINESS 1,356
4.2%
7 SOMNOLENCE 1,356
4.2%
8 INSOMNIA 1,243
3.8%
9 OFF LABEL USE 1,224
3.8%
10 FEELING ABNORMAL 1,181
3.6%
11 DEPRESSION 1,127
3.5%
12 PRESCRIBED OVERDOSE 1,115
3.4%
13 ABDOMINAL PAIN UPPER 1,110
3.4%
14 ANXIETY 1,032
3.2%
15 SUICIDAL IDEATION 1,003
3.1%
16 DECREASED APPETITE 962
3.0%
17 ABNORMAL BEHAVIOUR 957
2.9%
18 AGGRESSION 943
2.9%
19 WEIGHT INCREASED 886
2.7%
20 PAIN 867
2.7%
21 DRY MOUTH 779
2.4%
22 DISTURBANCE IN ATTENTION 761
2.3%
23 ASTHENIA 756
2.3%
24 WEIGHT DECREASED 736
2.3%
25 RASH 735
2.3%
26 CONFUSIONAL STATE 727
2.2%
27 DYSPNOEA 720
2.2%
28 PARAESTHESIA 715
2.2%
29 MEMORY IMPAIRMENT 695
2.1%
30 CONDITION AGGRAVATED 691
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.